|
?:authorAffiliation
|
-
[\'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Institute of Global Health, University of Siena, Siena, Italy.\', \'Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.\', \'International Vaccine Institute, Seoul, Korea.\', \'Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil; General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D\'Or de Pesquisa e Ensino, Salvador, Brazil.\', \'Universidade Federal de São Paulo, São Paulo, Brazil.\', \'General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D\'Or de Pesquisa e Ensino, Salvador, Brazil; Department of Pediatrics, Universidade Federal da Bahia, Salvador, Brazil.\', \'Instituto D\'Or de Pesquisa e Ensino, Salvador, Brazil.\', \'General Medicine, Hospital São Rafael, Salvador, Brazil; Instituto D\'Or de Pesquisa e Ensino, Salvador, Brazil.\', \'Instituto D\'Or de Pesquisa e Ensino, Salvador, Brazil; Gonçalo Moniz Institute, Fiocruz, Salvador, Brazil.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.\', \'Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.\', \'NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: andrew.pollard@paediatrics.ox.ac.uk.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}